Huang, X., Yuzefpolskaya, M., Colombo, P. C., Choe, J., Shertel, T., & Jennings, D. L. (2024). The Impact of Statin Intensity on the Early Progression of Cardiac Allograft Vasculopathy. Clinical Transplantation, 38(11). Portico. https://doi.org/10.1111/ctr.70030

Chakrani, Z., Patel, M., Mellgard, G., McCroskery, S., Saffran, N., Taylor, N., Liaw, B. C., Galsky, M., Oh, W., Tsao, C.-K., Ganta, T., & Patel, V. (2024). The Association of Statin Use With Survival Outcomes in Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC) Treated With Androgen Receptor Targeted Therapies (ART). Clinical Genitourinary Cancer, 22(6), 102227. https://doi.org/10.1016/j.clgc.2024.102227

Sharma, R., Simon, T. G., Hagström, H., Lochhead, P., Roelstraete, B., Söderling, J., Verna, E. C., Emond, J., & Ludvigsson, J. F. (2024). Statins Are Associated With a Decreased Risk of Severe Liver Disease in Individuals With Noncirrhotic Chronic Liver Disease. Clinical Gastroenterology and Hepatology, 22(4), 749-759.e19. https://doi.org/10.1016/j.cgh.2023.04.017

Wang, Y., Tinsley, B., Spolitu, S., Zadroga, J. A., Agarwal, H., Sarecha, A. K., & Ozcan, L. (2024). Geranylgeranyl isoprenoids and hepatic Rap1a regulate basal and statin-induced expression of PCSK9. Journal of Lipid Research, 65(3), 100515. https://doi.org/10.1016/j.jlr.2024.100515

Yoshida, Y., Jin, Z., Mannina, C., Homma, S., Nakanishi, K., Leibowitz, D., Elkind, M. S. V., Rundek, T., & Di Tullio, M. R. (2024). Aortic Arch Plaques and the Long-Term Risk of Stroke and Cardiovascular Events in the Statin Era. Stroke, 55(1), 69–77. https://doi.org/10.1161/strokeaha.123.044546

Lawal, K. O., Nilan, L., Amenta, J., McGuinness, J. E., Kukafka, R., & Crew, K. D. (2023). Comparing Breast Cancer and Cardiovascular Disease Risk and Use of Chemoprevention and Statins among Women with High-risk Breast Lesions. Cancer Prevention Research, 16(12), 661–667. https://doi.org/10.1158/1940-6207.capr-23-0181

Butler, M. J., Romain, A.-M. N., Augustin, R., Robles, P., Friel, C. P., Chandereng, T., Suls, J. M., Vrany, E. A., Vicari, F., Cheung, Y. K., & Davidson, K. W. (2023). The effect of a multi-component behavior change technique intervention on medication adherence among individuals on primary prevention statin therapy: a dose-finding protocol. Trials, 24(1). https://doi.org/10.1186/s13063-023-07549-w

Shah, R., Patel, N., Emin, M., Celik, Y., Jimenez, A., Gao, S., Garfinkel, J., Wei, Y., & Jelic, S. (2023). Statins Restore Endothelial Protection against Complement Activity in Obstructive Sleep Apnea: A Randomized Clinical Trial. Annals of the American Thoracic Society, 20(7), 1029–1037. https://doi.org/10.1513/annalsats.202209-761oc

Butler, M. J., Romain, A.-M. N., Augustin, R., Robles, P., Friel, C. P., Vicari, F., Chandereng, T., Alfano, C. M., Cheung, Y.-K., & Davidson, K. W. (2023). The effect of a multi-component behavior change technique intervention on physical activity among individuals on primary prevention statin therapy: A dose-finding trial protocol. Contemporary Clinical Trials, 130, 107205. https://doi.org/10.1016/j.cct.2023.107205

Bradley, C. K., Kolkailah, A. A., Shah, N. P., Page, C. B., Peterson, E. D., & Navar, A. M. (2023). Uptake of non-statin lipid-lowering therapies for secondary prevention in community practice. Journal of Clinical Lipidology, 17(3), 412–414. https://doi.org/10.1016/j.jacl.2023.03.006

Odden, M. C., Zhang, A., Jawadekar, N., Tan, A., Moran, A. E., Glymour, M. M., Brayne, C., Zeki Al Hazzouri, A., & Calonico, S. (2023). Regression discontinuity design to evaluate the effect of statins on myocardial infarction in electronic health records. European Journal of Epidemiology, 38(4), 393–402. https://doi.org/10.1007/s10654-023-00982-w

Cubeddu, R. J., Murphy, S. M. E., Asher, C. R., Garcia, S. A., Granada, J. F., Don, C. W., Patel, S., Albaghdadi, M. S., Cavalcante, J. L., Coylewright, M., Hahn, R. T., Genereux, P., Yadav, P. K., Thourani, V. H., & Leon, M. B. (2023). Association of ACEI/ARB and statin prescribing patterns with mortality after Transcatheter Aortic Valve Replacement (TAVR): Findings from real-world claims data. American Heart Journal, 258, 27–37. https://doi.org/10.1016/j.ahj.2022.12.012

Chen, P., Lazar, A., Ding, J., Siracuse, J. J., Patel, V. I., & Morrissey, N. J. (2023). Insurance status is associated with urgent carotid endarterectomy and worse postoperative outcomes. Journal of Vascular Surgery, 77(3), 818-826.e1. https://doi.org/10.1016/j.jvs.2022.10.007

Jennings, D. L., Sultan, L., Mingov, J., Choe, J., Latif, F., Restaino, S., Clerkin, K., Habal, M. V., Colombo, P. C., Yuzefpulskaya, M., Sayer, G., Uriel, N., & Baker, W. L. (2022). PCSK9 inhibitors safely and effectively lower LDL after heart transplantation: a systematic review and meta-analysis. Heart Failure Reviews, 28(1), 149–156. https://doi.org/10.1007/s10741-022-10255-5

Balkan, L., Ringel, J. B., Levitan, E. B., Khodneva, Y. A., Pinheiro, L. C., Sterling, M. R., Kim, S. M., Kronish, I. M., Jackson, E. A., Durant, R., Safford, M., & Goyal, P. (2022). Association of Perceived Stress With Incident Heart Failure. Journal of Cardiac Failure, 28(9), 1401–1410. https://doi.org/10.1016/j.cardfail.2022.04.013

Krishnamurthy, A., Bradley, C., Ascunce, R., & Kim, S. M. (2022). SAMSON and the Nocebo Effect: Management of Statin Intolerance. Current Cardiology Reports, 24(9), 1101–1108. https://doi.org/10.1007/s11886-022-01729-x

Kim, K., Ginsberg, H. N., & Choi, S. H. (2022). New, Novel Lipid-Lowering Agents for Reducing Cardiovascular Risk: Beyond Statins. Diabetes & Metabolism Journal, 46(4), 517–532. https://doi.org/10.4093/dmj.2022.0198

Wang, Y., Spolitu, S., Zadroga, J. A., Sarecha, A. K., & Ozcan, L. (2022). Hepatocyte Rap1a contributes to obesity- and statin-associated hyperglycemia. Cell Reports, 40(8), 111259. https://doi.org/10.1016/j.celrep.2022.111259

Kohli-Lynch, C. N., Lewsey, J., Boyd, K. A., French, D. D., Jordan, N., Moran, A. E., Sattar, N., Preiss, D., & Briggs, A. H. (2022). Beyond 10-Year Risk: A Cost-Effectiveness Analysis of Statins for the Primary Prevention of Cardiovascular Disease. Circulation, 145(17), 1312–1323. https://doi.org/10.1161/circulationaha.121.057631

Ginsberg, H. N., Hounslow, N. J., Senko, Y., Suganami, H., Bogdanski, P., Ceska, R., Kalina, A., Libis, R. A., Supryadkina, T. V., & Hovingh, G. K. (2022). Efficacy and Safety of K-877 (Pemafibrate), a Selective PPARα Modulator, in European Patients on Statin Therapy. Diabetes Care, 45(4), 898–908. https://doi.org/10.2337/dc21-1288

Acheampong, T., Lee Argov, E. J., Terry, M. B., Rodriguez, C. B., Agovino, M., Wei, Y., Athilat, S., & Tehranifar, P. (2022). Current regular aspirin use and mammographic breast density: a cross-sectional analysis considering concurrent statin and metformin use. Cancer Causes & Control, 33(3), 363–371. https://doi.org/10.1007/s10552-021-01530-1

Weintraub, W. S., Bhatt, D. L., Zhang, Z., Dolman, S., Boden, W. E., Bress, A. P., King, J. B., Bellows, B. K., Tajeu, G. S., Derington, C. G., Johnson, J., Andrade, K., Steg, P. G., Miller, M., Brinton, E. A., Jacobson, T. A., Tardif, J.-C., Ballantyne, C. M., & Kolm, P. (2022). Cost-effectiveness of Icosapent Ethyl for High-risk Patients With Hypertriglyceridemia Despite Statin Treatment. JAMA Network Open, 5(2), e2148172. https://doi.org/10.1001/jamanetworkopen.2021.48172